Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Brigham and Women's Hospital · Harvard University · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,988
total citations
- FWCI
- 97.94
- Percentile
- 100%
- References
- 51
Citations per year
Authors
29- RLRoss L. LevineCorresponding
Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute
- MWMartha Wadleigh
Harvard University
- JCJan Cools
Vlaams Instituut voor Biotechnologie, KU Leuven
- BLBenjamin L. Ebert
Broad Institute, Dana-Farber Cancer Institute
- GWGerlinde Wernig
Brigham and Women's Hospital, Harvard University
Topics & keywords
Topics
Keywords
- Essential thrombocythemia
- Myelofibrosis
- Polycythemia vera
- Myeloid
- Biology
- Missense mutation
- Cancer research
- Mutation
No related works found for this paper.